[Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]
- PMID: 29901305
[Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]
Abstract
This literature review focuses on the use of Serenoa repens extracts in the treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Extracts of Serenoa repens produce marked anti-inflammatory, anti-androgenic and antiproliferative effects. Various extracts differ in their activity depending on the concentration of free fatty acids and the method of extract preparation. Extracts of Serenoa Repens from different manufacturers vary considerably in composition, effectiveness and supporting evidence. Evaluation of the effectiveness of Serenoa Repens extracts should be carried out for each extract separately, depending on the method of preparation and brand. The most studied and clinically effective is the hexane lipidosterol extract of Serenoa Repens Permixon. This assessment is supported by a report on Serenoa Repens, issued by the European Medicines Agency. In this report, only Serenoa repens hexanic extract Permixon is considered to be a well-established medical use product for the symptomatic treatment of BPH.
Keywords: Permixon; Serenoa repens; benign prostatic hyperplasia; lower urinary tract symptoms.
Similar articles
-
Hexanic Extract of Serenoa repens (Permixon®): A Review in Symptomatic Benign Prostatic Hyperplasia.Drugs Aging. 2022 Mar;39(3):235-243. doi: 10.1007/s40266-022-00924-3. Epub 2022 Mar 3. Drugs Aging. 2022. PMID: 35237936 Free PMC article. Review.
-
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.Prostate. 2015 Dec;75(16):1857-67. doi: 10.1002/pros.23059. Epub 2015 Aug 26. Prostate. 2015. PMID: 26306400 Free PMC article. Clinical Trial.
-
[Iscussion on the use of hexane extract of Serenoa repens for combination therapy in patients with LUTS/BPH].Urologiia. 2021 Mar;(1):131-139. Urologiia. 2021. PMID: 33818949 Russian.
-
Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.Eur Urol Focus. 2016 Dec;2(5):553-561. doi: 10.1016/j.euf.2016.04.002. Epub 2016 Apr 23. Eur Urol Focus. 2016. PMID: 28723522 Review.
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. BJU Int. 2018. PMID: 29694707
Cited by
-
Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study.Ther Adv Urol. 2019 Jun 11;11:1756287219854923. doi: 10.1177/1756287219854923. eCollection 2019 Jan-Dec. Ther Adv Urol. 2019. PMID: 31217822 Free PMC article.
-
Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.Nutrients. 2022 Mar 11;14(6):1190. doi: 10.3390/nu14061190. Nutrients. 2022. PMID: 35334848 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical